 |
Hot Pursuit
08-Apr-23
|
|
|
|
|
|
|
|
|
|
|
|
US FDA concludes inspection at Alkem Labs' Ankleshwar unit with zero Form 483 observations
|
|
Alkem Laboratories said that the US FDA had conducted a good manufacturing practices (GMP) and pre-approval inspection at the company's API manufacturing facility located at Ankleshwar, Gujarat, from 03 April 2023 to 07 April 2023.
|
|
|
|
|
|
At the end of the inspection, no 'Form 483' was issued.
Alkem Laboratories is engaged in pharmaceutical business with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
The company's consolidated net profit declined 13.5% to Rs 454.71 crore despite of 16.1% rise in net sales to Rs 3,040.91 crore in Q3 FY23 over Q3 FY22.
The scrip had shed 0.45% to end at Rs 3392.75 on the BSE.
|
|
|
|
Previous News |
Alkem Laboratories
(
Results
-
Analysis
09-Aug-24
19:25
)
|
|
|
Indices trade with major gains; financial services edge higher
(
Market Commentary
-
Mid-Session
25-Jun-24
14:32
)
|
|
|
Alkem Lab reports cyber incident
(
Hot Pursuit
-
15-Jan-24
10:22
)
|
|
|
Alkem Laboratories Ltd soars 1.6%, Gains for third straight session
(
Hot Pursuit
-
07-Jun-24
13:05
)
|
|
|
Alkem Laboratories Ltd soars 1.08%, Gains for third straight session
(
Hot Pursuit
-
28-Aug-24
13:05
)
|
|
|
Sensex, Nifty end at record closing highs, Nifty Bank hits all-time high
(
Market Commentary
-
Quick Review
25-Jun-24
15:43
)
|
|
|
Alkem Laboratories consolidated net profit rises 87.56% in the September 2023 quarter
(
Results
-
Announcements
07-Nov-23
15:09
)
|
|
|
Zydus Lifesciences Ltd Slides 1.88%
(
Hot Pursuit
-
18-Jun-24
09:30
)
|
|
|
Alkem Lab reports cyber incident
(
Hot Pursuit
-
13-Jan-24
15:40
)
|
|
|
Alkem Laboratories Ltd spurts 0.13%, up for five straight sessions
(
Hot Pursuit
-
03-Feb-23
13:00
)
|
|
|
US FDA concludes inspection at Alkem Labs' Ankleshwar unit with zero Form 483 observations
(
Hot Pursuit
-
08-Apr-23
11:45
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|